TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34936159

Group type: EXPERIMENTAL
Intervention: Traditional lecture classroom
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mobile application
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of traditional lecture and mobile application
Number of subjects: 36
Study: 35576534

Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (CHO) group received 400 mL of a carbohydrate drink 2 to 3 hours before anesthesia
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group allowed clear fluid intake 2 hours before anesthesia
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (CHO) group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 34041713

Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Humalog®
Number of subjects: 190
Study: 34919684

Group type: EXPERIMENTAL
Intervention: Pro+SM (specifically tailored multistrain probiotic powder and micronutrient mixture)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Con+BM (control treatment consisting of placebo and basic care micronutrient mixture)
Number of subjects: 60
Study: 32894558

Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g), Alpha-Lactalbumin (50 mg), folic acid (200 µg) every morning for 6 months; Myo-inositol (600 mg), melatonin (1 mg), folic acid (200 µg) in the evening for 3 months before oocyte pick up; Myo-inositol (600 mg), folic acid (200 µg), melatonin (1 mg), vitamin D3 (50 µg) until the 12th week of gestation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group treated with 200 µg folic acid twice a day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Study group
Number of subjects: 100
Study: 35659181

Group type: EXPERIMENTAL
Intervention: Lumbosacral plexus block (LSPB) in the supine position
Number of subjects: 126

Group type: COMPARATOR
Intervention: Lumbosacral plexus block (LSPB) in the lateral position
Number of subjects: 126
Study: 36145188

Group type: EXPERIMENTAL
Intervention: Enzobiotic therapy (synbiotics and proteolytic enzymes) over 12 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 33187502

Group type: EXPERIMENTAL
Intervention: Near-peer instructor training
Number of subjects: 213

Group type: COMPARATOR
Intervention: Expert instructor training
Number of subjects: 213
Study: 35265960

Group type: EXPERIMENTAL
Intervention: 24 g whole dragon fruit powder (33 mg betalains)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 34593453

Group type: EXPERIMENTAL
Intervention: Sense of coherence (SOC) assessed using the SOC-13 questionnaire at 3-year follow-up
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Sense of coherence (SOC) assessed using the SOC-13 questionnaire at 5-year follow-up
Number of subjects: 406
Study: 32811539

Group type: EXPERIMENTAL
Intervention: Goal-directed human albumin substitution aimed at a concentration > 30 g/l during surgery and postanesthesia care unit stay.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard clinical care (Control group).
Number of subjects: 0
Study: 34958693

Group type: EXPERIMENTAL
Intervention: Combination of 4-hexylresorcinol (4-HR) and niacinamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Niacinamide alone
Number of subjects: 0
Study: 33482797

Group type: EXPERIMENTAL
Intervention: 980-nm diode laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (5 ml of 2.5% sodium hypochlorite, followed by 5 ml of 17% EDTA and 5 ml of distilled water)
Number of subjects: 30
Study: 35965169

Group type: EXPERIMENTAL
Intervention: Remotely-administered resilience- and wisdom-focused intervention (6 once-a-week one-hour sessions)
Number of subjects: 20
Study: 33164834

Group type: EXPERIMENTAL
Intervention: External Fixation (EF)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Intramedullary Nailing (IMN)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 129
Study: 32341295

Group type: EXPERIMENTAL
Intervention: Low-energy femtosecond laser pretreatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional phacoemulsification (control)
Number of subjects: 40
Study: 32282520

Group type: EXPERIMENTAL
Intervention: Reduced flat times to 2 hours for venous and 4 hours for arterial
Number of subjects: 119
Study: 35306660

Group type: EXPERIMENTAL
Intervention: Resistant dextrin (10 g day‐1 for 8 weeks)
Number of subjects: 76
Study: 616782991

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine pattern-based clinical nursing care
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 160
Study: 35753560

Group type: EXPERIMENTAL
Intervention: MBSR
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: MBSR-B
Number of subjects: 99

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 99
Study: 33637348

Group type: EXPERIMENTAL
Intervention: VB-111 and weekly paclitaxel 80 mg/m2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Post-treatment fever
Number of subjects: 60
Study: 32726528

Group type: EXPERIMENTAL
Intervention: Nirsevimab (50 mg, single intramuscular injection)
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1453
Study: 34880671

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion during intraoperative period and 72 postoperative hours
Number of subjects: 260

Group type: COMPARATOR
Intervention: Normal saline infusion at the same volume, infusion rate, and timing
Number of subjects: 260
Study: 35955118

Group type: EXPERIMENTAL
Intervention: NMES to supraspinatus and posterior deltoid muscles
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study: 33885958

Group type: EXPERIMENTAL
Intervention: Deep learning–based denoising algorithm (DLA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Filtered Back Projection (FBP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ADMIRE
Number of subjects: 100
Study: 32279451

Group type: EXPERIMENTAL
Intervention: Liraglutide (0.9 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Empagliflozin (10 mg/day)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 64

Group type: COMPARATOR
Intervention: Empagliflozin
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Liraglutide and Empagliflozin
Number of subjects: 64
Study: 34773928

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cognitive behavioral relapse prevention therapy (RP)
Number of subjects: 81
Study: 32280057

Group type: EXPERIMENTAL
Intervention: Cortical step sign (CSS)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diameter difference sign (DDS)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clinically relevant maltorsion (CRM)
Number of subjects: 6
Study: 35670134

Group type: EXPERIMENTAL
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Xenogeneic Acellular Dermal Matrix (XDM)
Number of subjects: 50
Study: 33720541

Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed bimonthly (FBM) regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pro re nata (PRN) regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subretinal fluid (SRF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraretinal fluid (IRF)
Number of subjects: 0
Study: 33021196

Group type: EXPERIMENTAL
Intervention: Single-lens reflex (SLR) photo-grading
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Smartphone photo-grading
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Smartphone-CelScope device
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Smartphone images with a simple attachment
Number of subjects: 412
Study: 35576879

Group type: EXPERIMENTAL
Intervention: CDSS (PERI-KOAG)
Number of subjects: 168

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 168
Study: 36085294

Group type: EXPERIMENTAL
Intervention: CBD-rich cannabis treatment for 6 months
Number of subjects: 82
Study: 35971232

Group type: EXPERIMENTAL
Intervention: Prune juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34655431

Group type: EXPERIMENTAL
Intervention: Oxytocin (0.5 units IV bolus, adjusted by 0.25 units)
Number of subjects: 53
Study: 32561877

Group type: EXPERIMENTAL
Intervention: Pilates exercise program (PEP)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 236
Study: 34815548

Group type: EXPERIMENTAL
Intervention: Yoga for 6 weeks (n=14)
Number of subjects: 29
Study: 32102810

Group type: EXPERIMENTAL
Intervention: Trabeculotomy
Number of subjects: 248

Group type: COMPARATOR
Intervention: Combined trabeculotomy-trabeculectomy (CTT)
Number of subjects: 248

Group type: COMPARATOR
Intervention: CTT
Number of subjects: 248
Study: 33527740

Group type: EXPERIMENTAL
Intervention: Hybrid comprehensive telerehabilitation (HCTR)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 850
Study: 32068189

Group type: EXPERIMENTAL
Intervention: Education and problem-solving adherence intervention (8 sessions over 4 months)
Number of subjects: 200
Study: 34332363

Group type: EXPERIMENTAL
Intervention: Stress Management (SM)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cognitive Restructuring (CR)
Number of subjects: 126
Study: 32249112

Group type: EXPERIMENTAL
Intervention: Standard dose of ready-to-use therapeutic foods (RUTF)
Number of subjects: 801

Group type: COMPARATOR
Intervention: Reduced dose of ready-to-use therapeutic foods (RUTF)
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Both arms (Standard and Reduced dose of RUTF)
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Standard and Reduced dose of RUTF
Number of subjects: 801
Study: 36036648

Group type: EXPERIMENTAL
Intervention: Early rhythm control (ERC) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: AF ablation
Number of subjects: 0
Study: 33742603

Group type: EXPERIMENTAL
Intervention: 650 mg of decaffeinated green tea extract (dGTE) for 4 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA) for 4 weeks
Number of subjects: 8
Study: 33853415

Group type: EXPERIMENTAL
Intervention: Baseline concussion testing before the RoCKAS‐ST
Number of subjects: 229

Group type: COMPARATOR
Intervention: Baseline concussion testing after the RoCKAS‐ST
Number of subjects: 229
Study: 36214084

Group type: EXPERIMENTAL
Intervention: Facilitators of healthy dietary behaviour
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: External facilitators
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Internal barriers
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: External barriers
Number of subjects: 30
Study: 33578583

Group type: EXPERIMENTAL
Intervention: Digital practice group (n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n=12)
Number of subjects: 24
Study: 32173478

Group type: EXPERIMENTAL
Intervention: Blended current (Endocut Q)
Number of subjects: 928

Group type: COMPARATOR
Intervention: Forced coagulation current (Erbe Inc)
Number of subjects: 928
Study: 35277204

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 6119

Group type: COMPARATOR
Intervention: Bendroflumethiazide
Number of subjects: 6119
Study: 33068157

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (360 µg daily for 6 months)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 33369020

Group type: EXPERIMENTAL
Intervention: PRT + ProD (whey protein 20 g each morning plus 20 g postexercise and vitamin D3 2000 IU/day)
Number of subjects: 198

Group type: COMPARATOR
Intervention: PRT (no supplementation)
Number of subjects: 198
Study: 34217789

Group type: EXPERIMENTAL
Intervention: Radical irradiation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Partial irradiation
Number of subjects: 102

Group type: COMPARATOR
Intervention: No irradiation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Any irradiation (radical or partial)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Radical irradiation vs No irradiation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Radical vs Partial irradiation
Number of subjects: 102
Study: 33023513

Group type: EXPERIMENTAL
Intervention: 14‐h Youth MHFA course
Number of subjects: 384

Group type: COMPARATOR
Intervention: 15‐h Australian Red Cross Provide First Aid course
Number of subjects: 384
Study: 36181108

Group type: EXPERIMENTAL
Intervention: Antibiotics combined with mucosolvan perfusion therapy under fiber bronchoscope
Number of subjects: 120

Group type: COMPARATOR
Intervention: Antibiotics combined with mucosolvan lavage therapy under fiber bronchoscope
Number of subjects: 120
Study: 34225202

Group type: EXPERIMENTAL
Intervention: Simulated transport at -10°C
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Simulated transport
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Simulated transport for longer duration at -10°C
Number of subjects: 210
Study: 33263644

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg orally twice daily for 5 days)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Zanamivir (10 mg inhaled twice daily for 5 days)
Number of subjects: 160
Study: 34076770

Group type: EXPERIMENTAL
Intervention: Inside-stent therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional-stent therapy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Inside-stent therapy as second stent
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Technical and clinical success rate
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Re-intervention rate
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Second stent patency
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Survival probability
Number of subjects: 43
Study: 34473781

Group type: EXPERIMENTAL
Intervention: Chronological age standardization
Number of subjects: 554

Group type: COMPARATOR
Intervention: Corrected age standardization
Number of subjects: 554
Study: 36102002

Group type: EXPERIMENTAL
Intervention: Centrifugation (30 min daily)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Bed rest (55 days)
Number of subjects: 19
Study: 35227041

Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: G-premio Bond
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Single Bond Universal
Number of subjects: 108

Group type: COMPARATOR
Intervention: C-factor
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 vs flat wall and flat floor
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cavity wall and cavity floor
Number of subjects: 108
Study: 32187772

Group type: EXPERIMENTAL
Intervention: MTAD + PIPS
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: PIPS
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: MTAD
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl + 17% EDTA
Number of subjects: 55

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 55
Study: 34206160

Group type: EXPERIMENTAL
Intervention: iodine‐reduced kelp powder (6 g kelp powder corresponding to 3 g alginate/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: kelp‐free powder (placebo)
Number of subjects: 50
Study: 32291210

Group type: EXPERIMENTAL
Intervention: Short-term persistent negative symptoms (PNS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clozapine treatment (phase 3)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Negative symptoms (moderate severity)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4-week treatment
Number of subjects: 100
Study: 32500827

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic supplementation (2 capsules daily for six months)
Number of subjects: 70
Study: 33038501

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Education/support control
Number of subjects: 250
Study: 33530822

Group type: EXPERIMENTAL
Intervention: Relocation of intravenous pumps from bedside to outside the patient room using extension tubing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-pump relocation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-pump relocation
Number of subjects: 0
Study: 34752941

Group type: EXPERIMENTAL
Intervention: Two ketamine infusions (n=30; days 1 and 4)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Single ketamine infusion (n=24; only day 1)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal saline placebo infusion (n=24; only day 1)
Number of subjects: 78
Study: 32416376

Group type: EXPERIMENTAL
Intervention: 40 Gy in 5 fractions delivered every other day (EOD)
Number of subjects: 152

Group type: COMPARATOR
Intervention: 40 Gy in 5 fractions delivered once per week (QW)
Number of subjects: 152
Study: 34531554

Group type: EXPERIMENTAL
Intervention: Intrapolyp triamcinolone acetonide (TA) injection (20 mg/ml, 2 mL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo normal saline injection (2 mL)
Number of subjects: 43
Study: 32473928

Group type: EXPERIMENTAL
Intervention: LCD+INT (60 min/d of supervised interval exercise at 90% HRpeak for 3 min and 50% HRpeak for 3 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: LCD (mixed meals of 1200 kcal/d)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: LCD+INT
Number of subjects: 26

Group type: COMPARATOR
Intervention: LCD
Number of subjects: 26
Study: 34787917

Group type: EXPERIMENTAL
Intervention: PFMT + MVT
Number of subjects: 52

Group type: COMPARATOR
Intervention: PFMT + MST
Number of subjects: 52
Study: 34397879

Group type: EXPERIMENTAL
Intervention: Rational-emotive psychotherapy
Number of subjects: 568

Group type: COMPARATOR
Intervention: Waitlist group (Control)
Number of subjects: 568
Study: 32488332

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg qd
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rabeprazole 5 mg bid
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rabeprazole 5 mg qd
Number of subjects: 12
Study: 34487181

Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (n = 36)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Wait-list usual care (n = 18)
Number of subjects: 54
Study: 35436950

Group type: EXPERIMENTAL
Intervention: LPG cookstove and LPG in cylinders supplied throughout pregnancy until birth
Number of subjects: 4944

Group type: COMPARATOR
Intervention: Usual cooking practices (traditional stoves with biomass fuel)
Number of subjects: 4944

Group type: EXPERIMENTAL
Intervention: LPG cookstove
Number of subjects: 4944
Study: 34341409

Group type: EXPERIMENTAL
Intervention: Intrauterine antibiotic infusion (IAI) combined with oral antibiotic administration (OAA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral antibiotic administration (OAA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrauterine antibiotic infusion (IAI)
Number of subjects: 80
Study: 32636011

Group type: EXPERIMENTAL
Intervention: CDH
Number of subjects: 36

Group type: COMPARATOR
Intervention: ICE
Number of subjects: 36

Group type: COMPARATOR
Intervention: NON
Number of subjects: 36
Study: 36098291

Group type: EXPERIMENTAL
Intervention: Geriatric vulnerability score (GVS) of 1
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Geriatric vulnerability score (GVS) of 2
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Geriatric vulnerability score (GVS) of 3
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Geriatric vulnerability score (GVS) of 4
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Geriatric vulnerability score (GVS) of 5
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: GVS of 3 or more in validation cohort 1 (V1)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: GVS of 3 or more in validation cohort 2 (V2)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: GVS of 3 or more in validation cohort 3 (V3)
Number of subjects: 447
Study: 33547265

Group type: EXPERIMENTAL
Intervention: Velocity-based strength training with a 10% velocity loss (VL10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Traditional 1‐repetition maximum (1RM) based resistance training to failure (TRF)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 33380479

Group type: EXPERIMENTAL
Intervention: Double-task exercise programme with caregiver participation
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Double-task exercise programme without caregiver participation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Aerobic-balance-stretching exercise programme (control group)
Number of subjects: 300
Study: 33909348

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Anemic patients
Number of subjects: 802
Study: 32702468

Group type: EXPERIMENTAL
Intervention: Chlorpropamide–glibenclamide–basal insulin
Number of subjects: 2339

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2339
Study: 33940549

Group type: EXPERIMENTAL
Intervention: Group A: Left superior GP (LSGP) ‐ Left inferior GP (LIGP) ‐ Right inferior GP (RIGP) ‐ Right anterior GP (RAGP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Group B: RAGP ‐ LSGP ‐ LIGP ‐ RIGP
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups during ablation of RAGP
Number of subjects: 28
Study: 33248587

Group type: EXPERIMENTAL
Intervention: PAD63d
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: PAD77d
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study: 35833450

Group type: EXPERIMENTAL
Intervention: Palliative Medicine consultation within 24 hours
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 91
Study: 33387333

Group type: EXPERIMENTAL
Intervention: Ketamine infusions
Number of subjects: 127
Study: 32781360

Group type: EXPERIMENTAL
Intervention: PBMC-therapy (intrauterine administration of autologous hCG-activated PBMCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (PBS-injecting)
Number of subjects: 100
Study: 34162719

Group type: EXPERIMENTAL
Intervention: Poultry farming
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Atrazine use
Number of subjects: 427

Group type: COMPARATOR
Intervention: Villagers
Number of subjects: 427